Tech Company Financing Transactions
Advaxis Funding Round
Advaxis closed a $5 million financing round on 9/25/2009. Investors included private investors.
Transaction Overview
Company Name
Announced On
9/25/2009
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
305 College Rd. East
Princeton, NJ 08540
USA
Princeton, NJ 08540
USA
Phone
Website
Email Address
Not Recorded
Overview
Advaxis is a clinical-stage biotechnology company developing cancer immunotherapies that enlist the body's own immune system to fight cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kenneth Berlin
Chief Financial Officer
Molly Henderson
Chief Medical Officer
Andres Gutierrez
Chief Scientific Officer
Robert Petit
Browse more venture capital transactions:
Prev: 9/25/2009: LS9 venture capital transaction
Next: 9/28/2009: Egenera venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs